We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
15.50 | 0.98% | 1,599.00 | 1,599.50 | 1,600.50 | 1,600.00 | 1,575.00 | 1,579.50 | 5,149,016 | 16:35:14 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.37 | 65.87B |
TIDMGSK
RNS Number : 7807R
GlaxoSmithKline PLC
16 September 2014
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4 R(1)(c) GlaxoSmithKline plc (GSK) was advised on 15 September 2014 of the following increase in the notional allocation of GSK American Depositary Shares (ADSs) on 12 September 2014, at a price of $47.06 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401K plan:
Connected person Number of ADSs Dr K Slaoui (Connected person of Dr M Slaoui) 5 -----------------
V A Whyte
Company Secretary
16 September 2014
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSDQLBFZKFZBBK
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions